Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (15944)
All Articles published online
|
Publishing Process of This Article
|
Aug 28, 2016 (publication date) through Feb 6, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chan SL, Chong CC, Chan AW, Poon DM, Chok KS. Management of hepatocellular carcinoma with portal vein tumor thrombosis: Review and update at 2016. World J Gastroenterol 2016; 22(32): 7289-7300 [PMID: 27621575 DOI: 10.3748/wjg.v22.i32.7289] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i32/7289.htm |
| Number | Citing Articles |
| 1 |
Fayrouz O. Selim, Taghrid M. Abdalla, Thoraya A. M. Hosny. Thrombophilia in hepatocellular carcinoma. Egyptian Liver Journal 2019; 9(1) doi: 10.1186/s43066-019-0003-x
|
| 2 |
Ji Eun Han, Hyo Jung Cho, Soon Sun Kim, Jae Youn Cheong. Infiltrative hepatocellular carcinoma with multiple lung metastasis completely cured using nivolumab: a case report. Journal of Liver Cancer 2021; 21(2): 169 doi: 10.17998/jlc.2021.08.26
|
| 3 |
Minho Noh, Beom Kyung Kim, Seung Up Kim. Advanced Stage Hepatocellular Carcinoma Successfully Treated with Liver-directed Concurrent Chemoradiotherapy and Sequential Transarterial Radio-embolization. Journal of Liver Cancer 2021; 21(1): 97 doi: 10.17998/jlc.21.1.97
|
| 4 |
Tomotaka Kato, Atsushi Kudo, Yuko Kinowaki, Yoshiya Ishikawa, Shuichi Watanabe, Keiichi Akahoshi, Kosuke Ogawa, Hiroaki Ono, Daisuke Ban, Shinji Tanaka, Minoru Tanabe. A novel classification of portal venous tumor invasion to predict residual tumor status after surgery in patients with pancreatic neuroendocrine neoplasms. Journal of Cancer Research and Clinical Oncology 2022; 148(4): 931 doi: 10.1007/s00432-021-03660-0
|
| 5 |
Hao Sun, Bing Ma, Ning Sun, Han Bai, Xuejian Li, Chengshuo Zhang. Survival benefit of perioperative locoregional adjuvant treatment for hepatocellular carcinoma with portal vein tumor thrombosis: A systematic review and Bayesian network meta-analysis. Critical Reviews in Oncology/Hematology 2023; 189: 104083 doi: 10.1016/j.critrevonc.2023.104083
|
| 6 |
Xiaofan Feng, Tianyi Jiang, Chun Yang, Shujie Pang, Zhiwen Ding, Heping Hu, Hui Wang, Liwei Dong, Ning Yang. RPRD1A stabilizes NRF2 and aggravates HCC progression through competing with p62 for TRIM21 binding. Cell Death & Disease 2021; 13(1) doi: 10.1038/s41419-021-04447-4
|
| 7 |
Wen-juan Tong, Mei-qing Cheng, Man-xia Lin, Hang-tong Hu, Jia-min Pan, Hui Huang, Ying Wang, Xiao-yan Xie, Ming-de Lu, Ming Kuang, Yang Huang, Wei Wang. Identification of the origin of tumor in vein: comparison between CEUS LI-RADS v2017 and v2016 for patients at high risk. BMC Medical Imaging 2022; 22(1) doi: 10.1186/s12880-022-00912-4
|
| 8 |
Yashwant Patidar, Amar Mukund, Shiv K. Sarin. Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Tertiary Care Center Experience. Indian Journal of Radiology and Imaging 2021; 31(02): 270 doi: 10.1055/s-0041-1734367
|
| 9 |
Giulia Malaguarnera, Vito Emanuele Catania, Saverio Latteri, Antonio Maria Borzì, Gaetano Bertino, Roberto Madeddu, Filippo Drago, Michele Malaguarnera. Folate levels in hepatocellular carcinoma patients with portal vein thrombosis. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01525-3
|
| 10 |
Jina Kim, Jason Chia-Hsien Cheng, Taek-Keun Nam, Jin Hee Kim, Byoung Kuk Jang, Wen-Yen Huang, Hiroshi Aikata, Myungsoo Kim, Jung Hyun Kwon, Jinbo Yue, Victor Ho Fun Lee, Zhaochong Zeng, Jinsil Seong. Efficacy of Liver-Directed Combined Radiotherapy in Locally Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis. Cancers 2023; 15(12): 3164 doi: 10.3390/cancers15123164
|
| 11 |
Hongyu Pan, Liuyu Zhou, Zhuo Cheng, Jin Zhang, Ningjia Shen, Hongbin Ma, Yao Li, Riming Jin, Weiping Zhou, Dong Wu, Wen Sun, Ruoyu Wang. Perioperative Tislelizumab plus intensity modulated radiotherapy in resectable hepatocellular carcinoma with macrovascular invasion: a phase II trial. Nature Communications 2024; 15(1) doi: 10.1038/s41467-024-53704-5
|
| 12 |
Glen R. Morrell. Detection of Tumor Thrombus in Hepatocellular Carcinoma. Radiology 2022; 302(1): 116 doi: 10.1148/radiol.2021211984
|
| 13 |
Runze Xie, Maojun You, Xin Wang, Shunda Du, Fu-Sheng Wang, Pengyuan Yang. Multimodal Studies in Hepatitis B Virus Associated Hepatocellular Carcinoma. Infectious Diseases & Immunity 2022; 2(3): 204 doi: 10.1097/ID9.0000000000000052
|
| 14 |
Xuan-Hui Yan, Zhen-Dong Yue, Hong-Wei Zhao, Lei Wang, Zhen-Hua Fan, Yi-Fan Wu, Ming-Ming Meng, Ke Zhang, Li Jiang, Hui-Guo Ding, Yue-Ning Zhang, Yong-Ping Yang, Fu-Quan Liu. Transjugular intrahepatic portosystemic shunt with radioactive seed strand for main portal vein tumor thrombosis with cirrhotic portal hypertension. World Journal of Gastrointestinal Surgery 2022; 14(6): 567-579 doi: 10.4240/wjgs.v14.i6.567
|
| 15 |
Stephen L. Chan, Winnie Yeo, Frankie Mo, Anthony W.H. Chan, Jane Koh, Leung Li, Edwin P. Hui, Charing C.N. Chong, Paul B.S Lai, Tony S.K. Mok, Simon C.H. Yu. A phase 2 study of the efficacy and biomarker on the combination of transarterial chemoembolization and axitinib in the treatment of inoperable hepatocellular carcinoma. Cancer 2017; 123(20): 3977 doi: 10.1002/cncr.30825
|
| 16 |
Yuanqi Wang, Jingxian Shen, Shiting Feng, Ruiming Liang, Jiaming Lai, Dongming Li, Baogang Peng, Zaiguo Wang, Cheng Huang, Ming Kuang. Hepatic resection versus transarterial chemoembolization in infiltrative hepatocellular carcinoma: A multicenter study. Journal of Gastroenterology and Hepatology 2020; 35(12): 2220 doi: 10.1111/jgh.15060
|
| 17 |
Yue Hu, Min Zhou, Jing Tang, Shuang Li, Hongli Liu, Jianli Hu, Hong Ma, Junli Liu, Tingting Qin, Xiongjie Yu, Yongshun Chen, Jin Peng, Yanmei Zou, Tao Zhang, Jun Xue. Efficacy and Safety of Stereotactic Body Radiotherapy Combined with Camrelizumab and Apatinib in Patients with Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Clinical Cancer Research 2023; 29(20): 4088 doi: 10.1158/1078-0432.CCR-22-2592
|
| 18 |
Juxian Sun, Rongping Guo, Xinyu Bi, Mengchao Wu, Zhaoyou Tang, Wan Yee Lau, Shusen Zheng, Xuehao Wang, Jinming Yu, Xiaoping Chen, Jia Fan, Jiahong Dong, Yongjun Chen, Yunfu Cui, Chaoliu Dai, Chihua Fang, Shuang Feng, Zhili Ji, Weidong Jia, Ningyang Jia, Gong Li, Jing Li, Qiu Li, Jiangtao Li, Tingbo Liang, Lianxin Liu, Shichun Lu, Yi Lv, Yilei Mao, Yan Meng, Zhiqiang Meng, Feng Shen, Jie Shi, Huichuan Sun, Kaishan Tao, Gaojun Teng, Xuying Wan, Tianfu Wen, Liqun Wu, Jinglin Xia, Mingang Ying, Jian Zhai, Leida Zhang, Xuewen Zhang, Zhiwei Zhang, Haiping Zhao, Donghai Zheng, Xuting Zhi, Jie Zhou, Cuncai Zhou, Jian Zhou, Zhaochong Zeng, Kangshun Zhu, Minshan Chen, Jianqiang Cai, Shuqun Cheng. Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition). Liver Cancer 2022; 11(4): 315 doi: 10.1159/000523997
|
| 19 |
Jon M. Harrison, Amy Y. Li, John R. Bergquist, Fari Ngongoni, Jeffrey A. Norton, Monica M. Dua, George A. Poultsides, Brendan C. Visser. Revascularization techniques for complete portomesenteric venous occlusion in patients undergoing pancreatic resection. HPB 2024; 26(11): 1411 doi: 10.1016/j.hpb.2024.07.408
|
| 20 |
Houbin Sun, Minghui Zhang, Ruibao Liu, Yan Liu, Yingwen Hou, Changjun Wu.
Endovascular Implantation of
125
I Seed Combined with Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma
. Future Oncology 2018; 14(12): 1165 doi: 10.2217/fon-2017-0354
|
| 21 |
Tong Lin, Zhimei Lin, Peipei Mai, E Zhang, Lisheng Peng. Identification of prognostic biomarkers associated with the occurrence of portal vein tumor thrombus in hepatocellular carcinoma. Aging 2021; 13(8): 11786 doi: 10.18632/aging.202876
|
| 22 |
Lei Zhang, BinYan Zhong, Bo Hu, Wei Li, Peng Huang, Shen Zhang, JinJin Song, JianSong Ji, CaiFang Ni. Stratification of portal vein-invaded hepatocellular carcinoma treated with transarterial chemoembolization monotherapy. Journal of Interventional Medicine 2020; 3(4): 201 doi: 10.1016/j.jimed.2020.08.001
|
| 23 |
Riccardo De Robertis, Salvatore Paiella, Nicolò Cardobi, Luca Landoni, Paolo Tinazzi Martini, Silvia Ortolani, Giulia De Marchi, Stefano Gobbo, Alessandro Giardino, Giovanni Butturini, Giampaolo Tortora, Claudio Bassi, Mirko D’Onofrio. Tumor thrombosis: a peculiar finding associated with pancreatic neuroendocrine neoplasms. A pictorial essay. Abdominal Radiology 2018; 43(3): 613 doi: 10.1007/s00261-017-1243-z
|
| 24 |
Sang Jin Kim, Jong Man Kim. Liver transplantation for hepatocellular carcinoma with portal vein tumor thrombosis. Journal of Liver Cancer 2021; 21(2): 105 doi: 10.17998/jlc.2021.03.17
|
| 25 |
Piero Boraschi, Gaia Tarantini, Federica Pacciardi, Francescamaria Donati. Liver Diseases. 2020; : 479 doi: 10.1007/978-3-030-24432-3_42
|
| 26 |
Christos Sotiropoulos, Konstantinos Thomopoulos. Non-Traumatic Intramuscular Hip Hematoma in a Cirrhotic Patient With Hepatocellular Carcinoma and Portal Vein Thrombosis Treated With Sorafenib and Low Molecular Weight Heparin. Cureus 2021; doi: 10.7759/cureus.14818
|
| 27 |
Quan Wang, Xiaoquan Ji, Jing Sun, Wengang Li, Xuezhang Duan, Aimin Zhang. Comparison of stereotactic body radiotherapy with and without lenvatinib for advanced hepatocellular carcinoma: a propensity score analysis. Journal of Cancer Research and Clinical Oncology 2023; 149(10): 7441 doi: 10.1007/s00432-023-04652-y
|
| 28 |
Zi-Wen Tao, Bao-Quan Cheng, Tao Zhou, Yan-Jing Gao. Management of hepatocellular carcinoma patients with portal vein tumor thrombosis: A narrative review. Hepatobiliary & Pancreatic Diseases International 2022; 21(2): 134 doi: 10.1016/j.hbpd.2021.12.004
|
| 29 |
Ahmed Shehta, Ahmed Farouk, Ahmed Nabieh Elghawalby, Mohamed Elshobary, Ahmed Aboelenin, Amgad Fouad, Mahmoud Abdelwahab Ali. Outcomes of Hepatic Resection for Hepatocellular Carcinoma Associated with Portal Vein Invasion. Journal of Surgical Research 2021; 266: 269 doi: 10.1016/j.jss.2021.04.011
|
| 30 |
Nikhil Chauhan, Janet Bukovcan, Eveline Boucher, David Cosgrove, Julien Edeline, Bonnie Hamilton, Laura Kulik, Fayaz Master, Riad Salem. Intra-Arterial TheraSphere Yttrium-90 Glass Microspheres in the Treatment of Patients With Unresectable Hepatocellular Carcinoma: Protocol for the STOP-HCC Phase 3 Randomized Controlled Trial. JMIR Research Protocols 2018; 7(8): e11234 doi: 10.2196/11234
|
| 31 |
Yuk Ho Liu, Eugene Yee Juen Lo, Kit Fai Lee, Charing Ching Ning Chong, Paul Bo San Lai. An unusual cause of upper gastrointestinal bleeding due to recurrent hepatocellular carcinoma: A case report. International Journal of Surgery Case Reports 2020; 70: 83 doi: 10.1016/j.ijscr.2020.04.008
|
| 32 |
Bo Liu, Tianyu Xiong, Jian Lu, Shengwei Li, Xiangzhi Bai, Fugen Zhou, Qiuwen Wu. Technical note: A fast and accurate analytical dose calculation algorithm for 125I seed‐loaded stent applications. Medical Physics 2021; 48(11): 7493 doi: 10.1002/mp.15207
|
| 33 |
Zhu-Jian Deng, Le Li, Yu-Xian Teng, Yu-Qi Zhang, Yu-Xin Zhang, Hao-Tian Liu, Jian-Li Huang, Zhen-Xiu Liu, Liang Ma, Jian-Hong Zhong. Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and Controversy. Journal of Clinical and Translational Hepatology 2022; 10(1): 147 doi: 10.14218/JCTH.2021.00179
|
| 34 |
Jian Lu, Jin-He Guo, Jian-Song Ji, Yu-Liang Li, Wei-Fu Lv, Hai-Dong Zhu, Jun-Hui Sun, Wei-Xin Ren, Fu-Jun Zhang, Wei-Dong Wang, Hai-Bo Shao, Guang-Shao Cao, Hai-Liang Li, Kun Gao, Po Yang, Guo-Wen Yin, Guang-Yu Zhu, Fa-Zong Wu, Wu-Jie Wang, Dong Lu, Sheng-Qun Chen, Jie Min, Yang Zhao, Rui Li, Li-Gong Lu, Wan Yee Lau, Gao-Jun Teng. Irradiation stent with 125I plus TACE versus sorafenib plus TACE for hepatocellular carcinoma with major portal vein tumor thrombosis: a multicenter randomized trial. International Journal of Surgery 2023; 109(5): 1188 doi: 10.1097/JS9.0000000000000295
|
| 35 |
Hongjie Cai, Song Chen, Zhiqiang Wu, Fan Wang, Shuangyan Tang, Ludan Chen, Wenbo Guo. Atezolizumab Plus Bevacizumab Combined with Transarterial Embolization Plus Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma with a Diameter >8 Cm: A Retrospective Study. Journal of Hepatocellular Carcinoma 2024; : 399 doi: 10.2147/JHC.S439001
|
| 36 |
Yuki Ohya, Shintaro Hayashida, Akira Tsuji, Kunitaka Kuramoto, Hidekatsu Shibata, Hiroko Setoyama, Hironori Hayashi, Kazumi Kuriwaki, Masato Sasaki, Masayoshi Iizaka, Osamu Nakahara, Yukihiro Inomata. Conversion hepatectomy for advanced hepatocellular carcinoma after right portal vein transection and lenvatinib therapy. Surgical Case Reports 2020; 6(1) doi: 10.1186/s40792-020-01078-3
|
| 37 |
Lujun Shen, Mian Xi, Lei Zhao, Xuhui Zhang, Xiuchen Wang, Zhimei Huang, Qifeng Chen, Tianqi Zhang, Jingxian Shen, Mengzhong Liu, Jinhua Huang. Combination Therapy after TACE for Hepatocellular Carcinoma with Macroscopic Vascular Invasion: Stereotactic Body Radiotherapy versus Sorafenib. Cancers 2018; 10(12): 516 doi: 10.3390/cancers10120516
|
| 38 |
Fei‐Pang Kuo, Tzu‐Hsuan Cheng, Yu‐Ming Cheng, Chao‐Chuan Wu, Chia‐Chi Wang. Effectiveness of multimodality treatment for hepatocellular carcinoma patients with portal vein thrombosis: A real world experience. Advances in Digestive Medicine 2022; 9(3): 168 doi: 10.1002/aid2.13275
|
| 39 |
Maria Guarino, Alessandro Cucchetti, Giuseppina Pontillo, Fabio Farinati, Francesca Benevento, Gian Ludovico Rapaccini, Maria Di Marco, Eugenio Caturelli, Marco Zoli, Sacco Rodolfo, Giuseppe Cabibbo, Fabio Marra, Andrea Mega, Antonio Gasbarrini, Gianluca Svegliati‐Baroni, Francesco Giuseppe Foschi, Gabriele Missale, Alberto Masotto, Gerardo Nardone, Giovanni Raimondo, Francesco Azzaroli, Gianpaolo Vidili, Filippo Oliveri, Franco Trevisani, Edoardo G. Giannini, Filomena Morisco. Pattern of macrovascular invasion in hepatocellular carcinoma. European Journal of Clinical Investigation 2021; 51(7) doi: 10.1111/eci.13542
|
| 40 |
Shuheng Bai, YinYing Wu, Yanli Yan, Rong Li, Haojing Kang, Jiangzhou Zhang, Wen Ma, Ying Gao, Beina Hui, Hailin Ma, Xiaozhi Zhang, Juan Ren. Evaluation of the Efficacy and Toxicity of Radiotherapy for Type III-IV Portal Vein Tumor Thrombi. Technology in Cancer Research & Treatment 2021; 20 doi: 10.1177/1533033821995286
|
| 41 |
Kazuhiro Takahashi, Jaejeong Kim, Amane Takahashi, Shinji Hashimoto, Manami Doi, Kinji Furuya, Ryosuke Hashimoto, Yohei Owada, Koichi Ogawa, Yusuke Ohara, Yoshimasa Akashi, Katsuji Hisakura, Tsuyoshi Enomoto, Osamu Shimomura, Masayuki Noguchi, Tatsuya Oda. Conversion hepatectomy for hepatocellular carcinoma with main portal vein tumour thrombus after lenvatinib treatment: A case report. World Journal of Hepatology 2021; 13(3): 384-392 doi: 10.4254/wjh.v13.i3.384
|
| 42 |
Jenny Que, Hung-Chang Wu, Chia-Hui Lin, Chung-I Huang, Li-Ching Li, Chung-Han Ho. Comparison of stereotactic body radiation therapy with and without sorafenib as treatment for hepatocellular carcinoma with portal vein tumor thrombosis. Medicine 2020; 99(13): e19660 doi: 10.1097/MD.0000000000019660
|
| 43 |
Qunfang Zhou, Yongcheng An, Ting Liu, Zishan Liu, Ruixia Li, Chenmeng Wang, Feng Zhou, Congjuan Liu, Kangshun Zhu. Prognosis of patients with hepatocellular carcinoma and portal vein tumor thrombus treated with combination of transarterial chemoembolization and palliative thermal ablation. International Journal of Hyperthermia 2022; 39(1): 97 doi: 10.1080/02656736.2021.2021303
|
| 44 |
Neel Shroff, Woongsoon Choi, Mohamed Elshikh, Brian Wong, Peeyush Bhargava. Multimodality imaging approach in identifying invasive hepatocellular carcinoma. Clinical Imaging 2023; 97: 34 doi: 10.1016/j.clinimag.2023.03.002
|
| 45 |
Jun Tao Huang, Jian-Hong Zhong, Jie Zhang, Wen Feng Gong, Liang Ma, Le Qun Li, Bang-De Xiang. Hepatectomy combined with apatinib and camrelizumab for CNLC stage IIIb hepatocellular carcinoma: a phase II trial protocol. BMJ Open 2023; 13(9): e067730 doi: 10.1136/bmjopen-2022-067730
|
| 46 |
Mohamed Elgazzar, Tary Salman, Eman Abdelsameea, Mohamed Akl, Nabil Omar, Mohamed Abdel-Samiee, Shrif Abas, Mohmoud Elsakhawy, Ahmed Elsherif, Ibrahim Abdelkader, Dina Elazab, Nermine Ehsan, Mohamed Mohamady, Mohamed El-Kassas, Hazem Metwaly Omar. Hepatocellular carcinoma in hepatitis C virus patients treated with direct acting antivirals (DAAs) and patients not exposed to DAAs: a large center comparative study. Egyptian Journal of Radiology and Nuclear Medicine 2024; 55(1) doi: 10.1186/s43055-024-01249-4
|
| 47 |
Sun Hyun Bae, Won Il Jang, Hee Chul Park. Intensity-modulated radiotherapy for hepatocellular carcinoma: dosimetric and clinical results. Oncotarget 2017; 8(35): 59965 doi: 10.18632/oncotarget.19219
|
| 48 |
Zhiqiang Wu, Jian Gao, Wenquan Zhuang, Jianyong Yang, Wenbo Guo. Efficacy and safety of transcatheter arterial chemoembolization plus hepatic arterial infusion chemotherapy in the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis in the main trunk. Journal of Cancer Research and Therapeutics 2022; 18(2): 345 doi: 10.4103/jcrt.jcrt_1078_21
|
| 49 |
Hideki Iwamoto, Takashi Niizeki, Hiroaki Nagamatsu, Kazuomi Ueshima, Takako Nomura, Teiji Kuzuya, Kazuhiro Kasai, Yohei Kooka, Atsushi Hiraoka, Rie Sugimoto, Takehiro Yonezawa, Akio Ishihara, Akihiro Deguchi, Hirotaka Arai, Shigeo Shimose, Tomotake Shirono, Masahito Nakano, Shusuke Okamura, Yu Noda, Naoki Kamachi, Miwa Sakai, Hiroyuki Suzuki, Hajime Aino, Norito Matsukuma, Satoru Matsugaki, Kei Ogata, Yoichi Yano, Takato Ueno, Masahiko Kajiwara, Satoshi Itano, Kunitaka Fukuizumi, Hiroshi Kawano, Kazunori Noguchi, Masatoshi Tanaka, Taizo Yamaguchi, Ryoko Kuromatsu, Atsushi Kawaguchi, Hironori Koga, Takuji Torimura. Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular Carcinoma. Cancers 2021; 13(4): 646 doi: 10.3390/cancers13040646
|
| 50 |
Xiang-quan Kong, Ya-ping Dong, Jun-xin Wu, Jun-yan He, Yu-yin Le, Kai-xin Du, Qing-qin Peng, Jin-luan Li. High-biologically effective dose palliative radiotherapy for a tumor thrombus might improve the long-term prognosis of hepatocellular carcinoma: a retrospective study. Radiation Oncology 2017; 12(1) doi: 10.1186/s13014-017-0831-y
|
| 51 |
Jae Seok Bae, Jeong Min Lee, Sun Kyung Jeon, Jeongin Yoo, Sae-Jin Park, Jeong Hee Yoon, Ijin Joo, Kyoung-Bun Lee, Haeryoung Kim. LI-RADS Tumor in Vein at CT and Hepatobiliary MRI. Radiology 2022; 302(1): 107 doi: 10.1148/radiol.2021210215
|
| 52 |
Yongjie Shui, Wei Yu, Xiaoqiu Ren, Yinglu Guo, Jing Xu, Tao Ma, Bicheng Zhang, Jianjun Wu, Qinghai Li, Qiongge Hu, Li Shen, Xueli Bai, Tingbo Liang, Qichun Wei. Stereotactic body radiotherapy based treatment for hepatocellular carcinoma with extensive portal vein tumor thrombosis. Radiation Oncology 2018; 13(1) doi: 10.1186/s13014-018-1136-5
|
| 53 |
Lucia Cerrito, Brigida Eleonora Annicchiarico, Roberto Iezzi, Antonio Gasbarrini, Maurizio Pompili, Francesca Romana Ponziani. Treatment of hepatocellular carcinoma in patients with portal vein tumor thrombosis: Beyond the known frontiers. World Journal of Gastroenterology 2019; 25(31): 4360-4382 doi: 10.3748/wjg.v25.i31.4360
|
| 54 |
Phillip Esposito, Mika Matteo, Carissa Concepcion, Matthew Montanarella, Jerry Matteo. Portal Vein Tumor Thrombus: No Longer a Death Sentence. Cureus 2021; doi: 10.7759/cureus.12845
|
| 55 |
Hsin-Yu Kuo, Nai-Jung Chiang, Chiao-Hsiung Chuang, Chiung-Yu Chen, I-Chin Wu, Ting-Tsung Chang, Hong-Ming Tsai, Yih-Jyh Lin. Impact of Immune Checkpoint Inhibitors with or without a Combination of Tyrosine Kinase Inhibitors on Organ-Specific Efficacy and Macrovascular Invasion in Advanced Hepatocellular Carcinoma. Oncology Research and Treatment 2020; 43(5): 211 doi: 10.1159/000505933
|
| 56 |
Ziwen Tao, Yuying Ruan, Zhi Peng, Kai Zhang, Yanjing Gao. Transarterial Chemoembolization Combined With Endoscopic Therapy Is Beneficial for Unresectable Hepatocellular Carcinoma With Esophagogastric Varices. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.783574
|
| 57 |
Guosheng Yuan, Xiao Cheng, Qi Li, Mengya Zang, Wei Huang, Wenzhe Fan, Tao Wu, Jian Ruan, Wencong Dai, Wenxuan Yu, Mian Chen, Yabing Guo, Xiaoyun Hu, Jinzhang Chen. <p>Safety and Efficacy of Camrelizumab Combined with Apatinib for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Multicenter Retrospective Study</p>. OncoTargets and Therapy 2020; : 12683 doi: 10.2147/OTT.S286169
|
| 58 |
Wangyi Xuan, Xiaoming Zhang, Yingying Fang, Yueming Zhang, Zhiyi Xiang, Yifei Yu, Qingping Wu, Xingfen Zhang. Efficacy and safety of neoadjuvant therapy for hepatocellular carcinoma with portal vein thrombosis: A meta‑analysis. Oncology Letters 2025; 29(3) doi: 10.3892/ol.2025.14868
|
| 59 |
Wenzhe Fan, Guosheng Yuan, Huishuang Fan, Fuliang Li, Yanqin Wu, Yue Zhao, Wang Yao, Yu Wang, Miao Xue, Jianyong Yang, Jiaping Li. Apatinib Combined With Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus: A Multicenter Retrospective Study. Clinical Therapeutics 2019; 41(8): 1463 doi: 10.1016/j.clinthera.2019.04.036
|
| 60 |
Guangxin Li, Bin Shu, Zhuozhao Zheng, Hongfang Yin, Chen Zhang, Ying Xiao, Yanmei Yang, Zhe Yan, Xiaofei Zhang, Shizhong Yang, Gong Li, Jiahong Dong. Safety and efficacy of radiotherapy combined with lenvatinib plus PD-1 inhibitors as neo-adjuvant therapy in hepatocellular carcinoma with portal vein thrombus: protocol of an open-label, single-arm, prospective, multi-center phase I trial. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1051916
|
| 61 |
Mélanie Wilbaux, David Demanse, Yi Gu, Astrid Jullion, Andrea Myers, Vasiliki Katsanou, Christophe Meille. Contribution of machine learning to tumor growth inhibition modeling for hepatocellular carcinoma patients under Roblitinib (FGF401) drug treatment. CPT: Pharmacometrics & Systems Pharmacology 2022; 11(8): 1122 doi: 10.1002/psp4.12831
|
| 62 |
Xiao-fei Zhang, Lin Lai, Hui Zhou, Yuan-jun Mo, Xu-quan Lu, Min Liu, Yun-xin Lu, En-cun Hou, Gregory Tiao. Stereotactic body radiotherapy plus transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma patients with portal vein tumour thrombus: A meta-analysis. PLOS ONE 2022; 17(5): e0268779 doi: 10.1371/journal.pone.0268779
|
| 63 |
Xiaodong Song, Yong He, Huihong Liang, Menling Han, Zili Shao. INTRABEAM intraoperative radiotherapy combined with portal vein infusion chemotherapy for treating hepatocellular carcinoma with portal vein tumor thrombus. BMC Surgery 2020; 20(1) doi: 10.1186/s12893-020-00836-2
|
| 64 |
Zun-Yi Zhang, Er-Lei Zhang, Bi-Xiang Zhang, Xiao-Ping Chen, Wei Zhang. Treatment for hepatocellular carcinoma with tumor thrombosis in the hepatic vein or inferior vena cava: A comprehensive review. World Journal of Gastrointestinal Surgery 2021; 13(8): 796-805 doi: 10.4240/wjgs.v13.i8.796
|
| 65 |
Luca Filippi, Giovan G. Di Costanzo, Antonio D’Agostini, Raffaella Tortora, Giuseppe Pelle, Roberto Cianni, Orazio Schillaci, Oreste Bagni. Decrease in total lesion glycolysis and survival after yttrium-90-radioembolization in poorly differentiated hepatocellular carcinoma with portal vein tumour thrombosis. Nuclear Medicine Communications 2018; 39(9): 845 doi: 10.1097/MNM.0000000000000879
|
| 66 |
Peyda Korhan, Yeliz Yılmaz, Ezgi Bağırsakçı, Ayşim Güneş, Hande Topel, Brian I. Carr, Neşe Atabey. Pleiotropic Effects of Heparins: From Clinical Applications to Molecular Mechanisms in Hepatocellular Carcinoma. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/7568742
|
| 67 |
Yin Cao, WenWen Ding, JingZi Zhang, Qi Gao, HaoXiang Yang, WangSen Cao, ZhongXia Wang, Lei Fang, RongHui Du. Significant Down-Regulation of Urea Cycle Generates Clinically Relevant Proteomic Signature in Hepatocellular Carcinoma Patients with Macrovascular Invasion. Journal of Proteome Research 2019; 18(5): 2032 doi: 10.1021/acs.jproteome.8b00921
|
| 68 |
Jian-Hai Guo, Shao-Xing Liu, Song Gao, Fu-Xin Kou, Xin Zhang, Di Wu, Xiao-Ting Li, Hui Chen, Xiao-Dong Wang, Peng Liu, Peng-Jun Zhang, Hai-Feng Xu, Guang Cao, Lin-Zhong Zhu, Ren-Jie Yang, Xu Zhu. Transarterial chemoembolization with hepatic arterial infusion chemotherapy plus S-1 for hepatocellular carcinoma. World Journal of Gastroenterology 2020; 26(27): 3971 doi: 10.3748/wjg.v26.i27.3971
|
| 69 |
Haeryoung Kim, Wei-Qiang Leow, Regina Lo, Paulo Giovanni L. Mendoza, Anthony Wing-Hung Chan. Atlas of Hepatocellular Carcinoma Pathology. 2022; : 145 doi: 10.1007/978-981-16-8500-2_16
|
| 70 |
Claudia Wing‐Kwan Wu, Grace Lai‐Hung Wong, Vincent Wai‐Sun Wong, Tsz‐Fai Yam, Terry Cheuk‐Fung Yip, Angus Chun‐Hei Wong, Brian Wai‐Nok Chan, Matthew Man‐Lok Fong, Jimmy Che‐To Lai, Yee‐Kit Tse, Kit‐Fai Lee, Tony Shu‐Kam Mok, Henry Lik‐Yuen Chan, Rashid Nok‐Shun Lui, Stephen Lam Chan, Kelvin Kwok‐Chai Ng. Baveno VII criteria identify varices needing treatment in patients with hepatocellular carcinoma of different Barcelona Clinic Liver Cancer stages. Journal of Gastroenterology and Hepatology 2023; 38(8): 1381 doi: 10.1111/jgh.16218
|
| 71 |
Junqing Lin, Han Jiang, Weizhu Yang, Na Jiang, Qubin Zheng, Ning Huang, Xiaolong Wang, Ang Li, Jingyao Huang. Predictive factors of benefit from iodine-125 brachytherapy for hepatocellular carcinoma with portal vein tumor thrombosis. Brachytherapy 2019; 18(2): 233 doi: 10.1016/j.brachy.2018.10.002
|
| 72 |
Ying Wu, Han Qi, Fei Cao, Lujun Shen, Shuanggang Chen, Lin Xie, Tao Huang, Ze Song, Danyang Zhou, Weijun Fan. TACE-Sorafenib With Thermal Ablation Has Survival Benefits in Patients With Huge Unresectable Hepatocellular Carcinoma. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.01130
|
| 73 |
Hideki Iwamoto, Takashi Niizeki, Hiroaki Nagamatsu, Kazuomi Ueshima, Joji Tani, Teiji Kuzuya, Kazuhiro Kasai, Youhei Kooka, Atsushi Hiraoka, Rie Sugimoto, Takehiro Yonezawa, Satoshi Tanaka, Akihiro Deguchi, Shigeo Shimose, Tomotake Shirono, Miwa Sakai, Hiroyuki Suzuki, Etsuko Moriyama, Hironori Koga, Takuji Torimura, Takumi Kawaguchi. The Clinical Impact of Hepatic Arterial Infusion Chemotherapy New-FP for Hepatocellular Carcinoma with Preserved Liver Function. Cancers 2022; 14(19): 4873 doi: 10.3390/cancers14194873
|
| 74 |
Dora Krisztina Tihanyi, Attila Szijarto, Andras Fülöp, Bernd Denecke, Georg Lurje, Ulf Peter Neumann, Zoltan Czigany, Rene Tolba. Systematic Review on Characteristics and Reporting Quality of Animal Studies in Liver Regeneration Triggered by Portal Vein Occlusion and Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy: Adherence to the ARRIVE Guidelines. Journal of Surgical Research 2019; 235: 578 doi: 10.1016/j.jss.2018.10.038
|
| 75 |
Emily L. Ryon, Joshua P. Kronenfeld, Rachel M. Lee, Adam Yopp, Annie Wang, Ann Y. Lee, Sommer Luu, Cary Hsu, Eric Silberfein, Maria C. Russell, Neha Goel, Nipun B. Merchant, Jashodeep Datta. Surgical management of hepatocellular carcinoma patients with portal vein thrombosis: The United States Safety Net and Academic Center Collaborative Analysis. Journal of Surgical Oncology 2021; 123(2): 407 doi: 10.1002/jso.26282
|
| 76 |
Tao Sun, Lei Chen, Xuefeng Kan, Yanqiao Ren, Yanyan Cao, Weihua Zhang, Haohao Lu, Chuansheng Zheng, San Lin You. A Comparative Analysis of Efficacy of Apatinib Combined with Transarterial Chemoembolization and Transarterial Chemoembolization Alone in the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/1255133
|
| 77 |
Ningbin Luo, Wenzhu Li, Jisheng Xie, Danhui Fu, Lidong Liu, Xiangyang Huang, Danke Su, Guanqiao Jin. Preoperative normalized iodine concentration derived from spectral CT is correlated with early recurrence of hepatocellular carcinoma after curative resection. European Radiology 2021; 31(4): 1872 doi: 10.1007/s00330-020-07330-6
|
| 78 |
Diego A.S. Toesca, Aisling Barry, Gonzalo Sapisochin, Robert Beecroft, Laura Dawson, Dawn Owen, Samdeep Mouli, Robert Lewandowski, Riad Salem, Daniel T. Chang. Clinical Case Panel: Treatment Alternatives for Inoperable Hepatocellular Carcinoma. Seminars in Radiation Oncology 2018; 28(4): 295 doi: 10.1016/j.semradonc.2018.08.001
|
| 79 |
Hiroyuki Kato, Yukio Asano, Masahiro Ito, Satoshi Arakawa, Masahiro Shimura, Daisuke Koike, Takayuki Ochi, Hironobu Yasuoka, Toki Kawai, Takahiko Higashiguchi, Hiroki Tani, Yoshiki Kunimura, Yuka Kondo, Hidetoshi Nagata, Harunobu Sato, Akihiko Horiguchi. A case of Vp4 hepatocellular carcinoma with tumor thrombosis extending into the confluence of the splenic/portal vein achieved a good prognosis with emergent hepatectomy and postoperative adjuvant therapy with lenvatinib. World Journal of Surgical Oncology 2022; 20(1) doi: 10.1186/s12957-022-02740-w
|
| 80 |
Paschalis Gavriilidis, Timothy M Pawlik, Daniel Azoulay. Comprehensive review of hepatocellular carcinoma with portal vein tumor thrombus: State of art and future perspectives. Hepatobiliary & Pancreatic Diseases International 2024; 23(3): 221 doi: 10.1016/j.hbpd.2023.10.009
|
| 81 |
Saikang Tang, Yingming Gao, Xue Yan, Weihua Zhi, Yue Han. Effectiveness and safety of vascular intervention plus lenvatinib versus vascular intervention alone for hepatocellular carcinoma patients with portal vein tumor thrombus: a retrospective comparative study. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1431069
|
| 82 |
Motaz Qadan, Nishita Kothary, Bruno Sangro, Manisha Palta. The Treatment of Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis. American Society of Clinical Oncology Educational Book 2020; (40): 174 doi: 10.1200/EDBK_280811
|
| 83 |
Eric A. Wang, Jeff P. Stein, Ross J. Bellavia, Scott R. Broadwell. Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres. International Journal of Clinical Practice 2017; 71(11): e12972 doi: 10.1111/ijcp.12972
|
| 84 |
Tyng-Yuan Jang, Ching-I. Huang, Ming-Lun Yeh, Zu-Yau Lin, Shinn-Cherng Chen, Wan-Long Chuang. The prognosis of bulky hepatocellular carcinoma with nonmajor branch portal vein tumor thrombosis. Medicine 2019; 98(13): e15066 doi: 10.1097/MD.0000000000015066
|
| 85 |
Zunyi Zhang, Erlei Zhang. Conversion therapy for advanced hepatocellular carcinoma with vascular invasion: a comprehensive review. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1073531
|
| 86 |
Is hepatocellular carcinoma complicated with portal vein tumor thrombosis potentially curable by radiotherapy in the form of stereotactic body radiation therapy?. International Journal of Radiation Biology 2022; 98(10): 1495 doi: 10.1080/09553002.2022.2055800
|
| 87 |
Guangxin Li, Ying Zhao, Keren Li, Shizhong Yang, Canhong Xiang, Jiyong Song, Yanmei Yang, Gong Li, Jiahong Dong. Effectiveness and Safety of the PD-1 Inhibitor Lenvatinib Plus Radiotherapy in Patients with HCC with Main PVTT: Real-World Data from a Tertiary Centre. Journal of Hepatocellular Carcinoma 2023; : 2037 doi: 10.2147/JHC.S432542
|
| 88 |
Monika Wójcik-Giertuga, Anna Malczewska-Herman, Beata Kos-Kudła. The Risk of Venous Thromboembolism in Neuroendocrine Neoplasms. Cancers 2023; 15(22): 5477 doi: 10.3390/cancers15225477
|
| 89 |
Fei Cao, Lujun Shen, Han Qi, Lin Xie, Ze Song, Shuanggang Chen, Weijun Fan. Tree-based classification system incorporating the HVTT-PVTT score for personalized management of hepatocellular carcinoma patients with macroscopic vascular invasion. Aging 2019; 11(21): 9544 doi: 10.18632/aging.102403
|
| 90 |
Hibiki Narita, Hideto Kawaratani, Akihiko Shibamoto, Soichi Takeda, Takahiro Ozutsumi, Yuki Tsuji, Yukihisa Fujinaga, Koh Kitagawa, Norihisa Nishimura, Daisuke Hokuto, Masayuki Sho, Hitoshi Yoshiji. Long-term survival with sorafenib-based multidisciplinary treatment for Vp4 hepatocellular carcinoma: a case report. Clinical Journal of Gastroenterology 2022; 15(5): 953 doi: 10.1007/s12328-022-01667-9
|
| 91 |
Aisling M. Glynn, Yaacov R. Lawrence, Laura A. Dawson, Aisling S. Barry. The use of precision radiotherapy for the management of cancer-related pain in the abdomen. Current Opinion in Supportive & Palliative Care 2025; 19(1): 51 doi: 10.1097/SPC.0000000000000738
|
| 92 |
Tianyu Jiao, Haowen Tang, Wenwen Zhang, Bingyang Hu, Tao Wan, Yinbiao Cao, Ze Zhang, Yafei Wang, Junning Cao, Mengqiu Cui, Shichun Lu. Long-term survival and portal vein patency with novel PVTT surgery approach in advanced HCC patients with Vp3/4 PVTT following combination therapy of TKIs and PD-1 inhibitors. BMC Surgery 2023; 23(1) doi: 10.1186/s12893-023-02291-1
|
| 93 |
Hao-Yang Tan, Shuang-Quan Liu, Jiu-Ling Zheng, Hong-Ying Liu, Yan-Han Liu, Guo-Hua Dai, Hua-Guo Feng. Efficacy of radiotherapy combined with hepatic arterial infusion chemotherapy, TKI and ICI for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective cohort study. Abdominal Radiology 2024; doi: 10.1007/s00261-024-04620-1
|
| 94 |
SalehA Alqahtani, FaisalM Sanai, Ashwaq Alolayan, Faisal Abaalkhail, Hamad Alsuhaibani, Mazen Hassanain, Waleed Alhazzani, Abdullah Alsuhaibani, Abdullah Algarni, Alejandro Forner, RichardS Finn, WaleedK Al-hamoudi. Saudi Association for the Study of Liver diseases and Transplantation practice guidelines on the diagnosis and management of hepatocellular carcinoma. Saudi Journal of Gastroenterology 2020; 26(7): 1 doi: 10.4103/sjg.SJG_477_20
|
| 95 |
Sofia Gereta, Judith Stangl‐Kremser, Tenny R. Zhang, Jim C. Hu. The Application of Heat in Oncology. 2023; : 425 doi: 10.1002/9781119799627.ch25
|
| 96 |
So Jung Lee, Myungsoo Kim, Yoo-Kang Kwak, Hye Jin Kang. MRI-guided radiotherapy for PVTT in HCC patients: evaluation of the efficacy and safety. Journal of Cancer Research and Clinical Oncology 2022; 148(9): 2405 doi: 10.1007/s00432-021-03788-z
|
| 97 |
Nokjung Kim, Myung-Won You. Hepatocellular carcinoma and macrovascular tumor thrombosis: treatment outcomes and prognostic factors for survival. Japanese Journal of Radiology 2019; 37(11): 781 doi: 10.1007/s11604-019-00868-6
|
| 98 |
Jian-Hai Guo, Shao-Xing Liu, Song Gao, Fu-Xin Kou, Xin Zhang, Di Wu, Xiao-Ting Li, Hui Chen, Xiao-Dong Wang, Peng Liu, Peng-Jun Zhang, Hai-Feng Xu, Guang Cao, Lin-Zhong Zhu, Ren-Jie Yang, Xu Zhu. Transarterial chemoembolization with hepatic arterial infusion chemotherapy plus S-1 for hepatocellular carcinoma. World Journal of Gastroenterology 2020; 26(27): 3975-3988 doi: 10.3748/wjg.v26.i27.3975
|
| 99 |
Fei Xu, Lulu Zhang, Wenting He, Di Song, Xiaomeng Ji, Jianyong Shao, Jie Mei. The Diagnostic Value of Serum PIVKA-II Alone or in Combination with AFP in Chinese Hepatocellular Carcinoma Patients. Disease Markers 2021; 2021: 1 doi: 10.1155/2021/8868370
|
| 100 |
Tae Won Choi, Jin Wook Chung. Radiation dose during transarterial chemoembolization and associated factors. Abdominal Radiology 2024; 49(11): 3935 doi: 10.1007/s00261-024-04370-0
|
| 101 |
Shuangxi Li, Lei Li, Baohua Li, Wenhui Wang. Safety and efficacy of endovascular implantation of a portal vein stent combined with iodine-125 seed-strips followed by transcatheter arterial chemoembolization with sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis. The British Journal of Radiology 2020; 93(1112) doi: 10.1259/bjr.20190279
|
| 102 |
Jin‐Cheng Wang, An‐Liang Xia, Yong Xu, Xiao‐Jie Lu. Comprehensive treatments for hepatocellular carcinoma with portal vein tumor thrombosis. Journal of Cellular Physiology 2019; 234(2): 1062 doi: 10.1002/jcp.27324
|
| 103 |
Chengjian He, Naijian Ge, Xiangdong Wang, Hai Li, Shiguang Chen, Yefa Yang. Conversion Therapy of Large Unresectable Hepatocellular Carcinoma With Ipsilateral Portal Vein Tumor Thrombus Using Portal Vein Embolization Plus Transcatheter Arterial Chemoembolization. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.923566
|
| 104 |
Feifei Mao, Yuqiang Cheng, Kang Wang, Zongtao Chai, Lei Guo, Yanyan Xu, Xue Chen, Jie Shi, Weixing Guo, Junling Liu, Shuqun Cheng. The KIT ligand KITLG promotes portal vein tumor thrombosis by up-regulating COL4A1 through STAT3-SMAD2 signaling in hepatocellular carcinoma. Acta Materia Medica 2024; 3(2) doi: 10.15212/AMM-2023-0049
|
| 105 |
Jian Lu, Xiu-Ping Zhang, Bin-Yan Zhong, Wan Yee Lau, David C Madoff, Jon C Davidson, Xiaolong Qi, Shu-Qun Cheng, Gao-Jun Teng. Management of patients with hepatocellular carcinoma and portal vein tumour thrombosis: comparing east and west. The Lancet Gastroenterology & Hepatology 2019; 4(9): 721 doi: 10.1016/S2468-1253(19)30178-5
|
| 106 |
Kentaro Iwaki, Toshimi Kaido, Gen Yamamoto, Naoko Kamo, Shintaro Yagi, Kojiro Taura, Shinji Uemoto. Mass-forming intrahepatic cholangiocarcinoma with portal vein tumor thrombus and bile duct tumor thrombus: A case report. International Journal of Surgery Case Reports 2017; 40: 13 doi: 10.1016/j.ijscr.2017.08.059
|
| 107 |
Kui Wu, Yongjie Shui, Wenzheng Sun, Sheng Lin, Haowen Pang. Utility of Radiomics for Predicting Patient Survival in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis Treated With Stereotactic Body Radiotherapy. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.569435
|
| 108 |
Seongmoon Jung, Sui Shen, Sung-Joon Ye. Dose perturbation and inhomogeneity of multi-arrays of 125I seed-loaded stent for treatment of portal vein tumor thrombosis. Physica Medica 2019; 66: 1 doi: 10.1016/j.ejmp.2019.09.077
|
| 109 |
Shiguang Chen, Bo Yuan, Wenchang Yu, Xiaolong Wang, Chengjian He, Chuanben Chen. Comparison of Arterial Infusion Chemotherapy and Chemoembolization for Locally Advanced Hepatocellular Carcinoma: a Multicenter Retrospective Study. Journal of Gastrointestinal Surgery 2022; 26(11): 2292 doi: 10.1007/s11605-022-05421-x
|
| 110 |
Hiroshi Doi, Hiroya Shiomi, Ryoong-Jin Oh. Management of Chronic Liver Diseases - Recent Advances. 2018; doi: 10.5772/intechopen.76505
|
| 111 |
Andrea Dalbeni, Filippo Cattazzo, Leonardo De Marco, Michele Bevilacqua, Mirko Zoncapè, Rosa Lombardi, Roberta Stupia, Anna Mantovani, David Sacerdoti. Bacterial infections as a risk factor for non-neoplastic portal vein thrombosis development in cirrhotic patients. Digestive and Liver Disease 2024; 56(3): 477 doi: 10.1016/j.dld.2023.09.012
|
| 112 |
Jia Yuan, Xin Yin, Bei Tang, Hui Ma, Lan Zhang, Lixin Li, Rongxin Chen, Xiaoying Xie, Zhenggang Ren. Transarterial Chemoembolization (TACE) Combined with Sorafenib in Treatment of HBV Background Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Propensity Score Matching Study. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/2141859
|
| 113 |
Zhenkang Qiu, Guobao Wang, Huzheng Yan, Han Qi, Mengxuan Zuo, Guisong Wang, Weiwei Jiang, Zixiong Chen, Jingbing Xue, Ligong Lu, Fujun Zhang, Fei Gao. TIPS plus sequential systemic therapy of advanced HCC patients with tumour thrombus-related symptomatic portal hypertension. European Radiology 2022; 32(10): 6777 doi: 10.1007/s00330-022-08705-7
|
| 114 |
Raffaella Tortora, Nunzia Farella, Filomena Morisco, Carmine Coppola, Francesco Izzo, Angelo Salomone Megna, Alessandro Federico, Vincenzo Messina, Gerardo Nardone, Guido Piai, Enrico Ragone, Luigi Elio Adinolfi, Giuseppe D’Adamo, Maria Stanzione, Giampiero Francica, Pietro Torre, Vincenzo De Girolamo, Nicola Coppola, Maria Guarino, Marcello Dallio, Lucia Rocco, Giovan Giuseppe Di Costanzo. Development of a risk score to predict portal vein tumor thrombosis in patients with hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology 2023; 35(7): 734 doi: 10.1097/MEG.0000000000002549
|
| 115 |
Yao Liu, Dongying Xue, Xiaogang Zhang, Fangyuan Gao, Le Sun, Xue Yang, Yuxin Li, Qun Zhang, Bingbing Zhu, Shuaishuai Niu, Yunyi Huang, Ying Hu, Xianbo Wang, Naohiko Masaki. Nomogram for Individualized Prediction of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis on Conservative Treatment. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/1473718
|
| 116 |
Nur Şener, Abdullah Yakupoğlu. Yttrium-90 transarterial radioembolization and capecitabine in hepatocellular carcinoma with portal vein involvement. Medicine 2023; 102(35): e34674 doi: 10.1097/MD.0000000000034674
|
| 117 |
Xuqi Sun, Qi Zhang, Jie Mei, Ziliang Yang, Minshan Chen, Tingbo Liang. Real-world efficiency of lenvatinib plus PD-1 blockades in advanced hepatocellular carcinoma: an exploration for expanded indications. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09405-7
|
| 118 |
Takako Nomura, Joji Tani, Akihiro Deguchi, Mai Nakahara, Kyoko Oura, Tomoko Tadokoro, Koji Fujita, Shima Mimura, Teppei Sakamoto, Asahiro Morishita, Hirohito Yoneyama, Hideki Kobara, Takayuki Sanomura, Yoshihiro Nishiyama, Keiichi Okano, Yasuyuki Suzuki, Shigeo Takahashi, Toru Shibata, Kunihiko Tsutsui, Takashi Himoto, Tsutomu Masaki. Efficacy of combined modality therapy with sorafenib following hepatic arterial injection chemotherapy and three‑dimensional conformal radiotherapy for advanced hepatocellular carcinoma with major vascular invasion. Molecular and Clinical Oncology 2019; doi: 10.3892/mco.2019.1920
|
| 119 |
Fabian Stoehr, Roman Kloeckner, Daniel Pinto dos Santos, Mira Schnier, Lukas Müller, Aline Mähringer-Kunz, Thomas Dratsch, Sebastian Schotten, Arndt Weinmann, Peter Robert Galle, Jens Mittler, Christoph Düber, Felix Hahn. Radiomics-Based Prediction of Future Portal Vein Tumor Infiltration in Patients with HCC—A Proof-of-Concept Study. Cancers 2022; 14(24): 6036 doi: 10.3390/cancers14246036
|
| 120 |
Saverio Latteri, Giulia Malaguarnera, Vito Emanuele Catania, Gaetano La Greca, Gaetano Bertino, Antonio Maria Borzì, Filippo Drago, Michele Malaguarnera. Homocysteine Serum Levels as Prognostic Marker of Hepatocellular Carcinoma with Portal Vein Thrombosis. Current Molecular Medicine 2019; 19(7): 532 doi: 10.2174/1566524019666190610120416
|
| 121 |
Scott M. Thompson, Michael L. Wells, James C. Andrews, Eric C. Ehman, Christine O. Menias, Christopher L. Hallemeier, Lewis R. Roberts, Sudhakar K. Venkatesh. Venous invasion by hepatic tumors: imaging appearance and implications for management. Abdominal Radiology 2018; 43(8): 1947 doi: 10.1007/s00261-017-1298-x
|
| 122 |
Chai Hong Rim, Chul Yong Kim, Dae Sik Yang, Won Sup Yoon. Comparison of radiation therapy modalities for hepatocellular carcinoma with portal vein thrombosis: A meta-analysis and systematic review. Radiotherapy and Oncology 2018; 129(1): 112 doi: 10.1016/j.radonc.2017.11.013
|
| 123 |
Hideki Iwamoto, Mika Nomiyama, Takashi Niizeki, Shigeo Shimose, Tomotake Shirono, Masahito Nakano, Manabu Satani, Syusuke Okamura, Yu Noda, Naoki Kamachi, Miwa Sakai, Hiroyuki Suzuki, Ryoko Kuromatsu, Etsuyo Ogo, Toshi Abe, Masatoshi Tanaka, Hironori Koga, Takuji Torimura. Dose and Location of Irradiation Determine Survival for Patients with Hepatocellular Carcinoma with Macrovascular Invasion in External Beam Radiation Therapy. Oncology 2019; 96(4): 192 doi: 10.1159/000495568
|
| 124 |
Shiguang Chen, Bo Yuan, Wenchang Yu, Xiaolong Wang, Chengjian He, Chuanben Chen. Hepatic arterial infusion oxaliplatin plus raltitrexed and chemoembolization in hepatocellular carcinoma with portal vein invasion: A propensity score‐matching cohort study. Journal of Surgical Oncology 2022; 126(7): 1205 doi: 10.1002/jso.27023
|
| 125 |
Mai Nakamura, Kyoji Ito, Nobuyuki Takemura, Fuminori Mihara, Norihiro Kokudo. Hepatectomy for liver metastases from cervical cancer with portal vein tumor thrombosis: a case report. Clinical Journal of Gastroenterology 2022; 15(2): 441 doi: 10.1007/s12328-022-01603-x
|
| 126 |
Walaa Abdelhamed, Hend Shousha, Mohamed El-Kassas. Portal vein tumor thrombosis in hepatocellular carcinoma patients: Is it the end?. Liver Research 2024; 8(3): 141 doi: 10.1016/j.livres.2024.09.002
|
| 127 |
Shuqun Cheng, Minshan Chen, Jianqiang Cai, Juxian Sun, Rongping Guo, Xinyu Bi, Wan Yee Lau, Mengchao Wu. Chinese Expert Consensus on Multidisciplinary Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus (2018 Edition). Liver Cancer 2020; 9(1): 28 doi: 10.1159/000503685
|